• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Thiazolides as novel antiviral agents. 1. Inhibition of hepatitis B virus replication.噻唑烷类化合物作为新型抗病毒药物。1. 抑制乙型肝炎病毒复制。
J Med Chem. 2011 Jun 23;54(12):4119-32. doi: 10.1021/jm200153p. Epub 2011 May 23.
2
Thiazolides as novel antiviral agents. 2. Inhibition of hepatitis C virus replication.噻唑烷类化合物作为新型抗病毒药物。2. 抑制丙型肝炎病毒复制。
J Med Chem. 2011 Dec 22;54(24):8670-80. doi: 10.1021/jm201264t. Epub 2011 Nov 21.
3
Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication.硝唑尼特、替唑尼特及其他噻唑酰胺类药物是乙型肝炎病毒和丙型肝炎病毒复制的强效抑制剂。
Antiviral Res. 2008 Jan;77(1):56-63. doi: 10.1016/j.antiviral.2007.08.005. Epub 2007 Sep 4.
4
Amidate Prodrugs of Deoxythreosyl Nucleoside Phosphonates as Dual Inhibitors of HIV and HBV Replication.脱氧苏糖核苷膦酸酯的酰胺化前药作为HIV和HBV复制的双重抑制剂
J Med Chem. 2016 Oct 27;59(20):9513-9531. doi: 10.1021/acs.jmedchem.6b01260. Epub 2016 Oct 17.
5
Synthesis and quantitative structure-activity relationships study for phenylpropenamide derivatives as inhibitors of hepatitis B virus replication.作为乙型肝炎病毒复制抑制剂的苯丙烯酰胺衍生物的合成及定量构效关系研究
Eur J Med Chem. 2015 Jun 24;99:82-91. doi: 10.1016/j.ejmech.2015.05.032. Epub 2015 May 28.
6
Design and synthesis of imidazole N-H substituted amide prodrugs as inhibitors of hepatitis C virus replication.作为丙型肝炎病毒复制抑制剂的咪唑N-H取代酰胺前药的设计与合成
Bioorg Med Chem Lett. 2015 Aug 15;25(16):3147-50. doi: 10.1016/j.bmcl.2015.06.006. Epub 2015 Jun 9.
7
Synthesis and pre-clinical studies of new amino-acid ester thiazolide prodrugs.新型氨基酸酯噻唑烷酮前药的合成与临床前研究
Eur J Med Chem. 2017 Jan 27;126:154-159. doi: 10.1016/j.ejmech.2016.09.080. Epub 2016 Sep 26.
8
Synthesis and antiviral evaluation of 2-amino-6-carbamoylpurine dioxolane nucleoside derivatives and their phosphoramidates prodrugs.2-氨基-6-氨基甲酰基嘌呤二氧戊环核苷衍生物及其磷酰胺酯前药的合成与抗病毒评价
Bioorg Med Chem. 2014 Dec 1;22(23):6665-6671. doi: 10.1016/j.bmc.2014.10.003. Epub 2014 Oct 13.
9
4-Substituted-2-Thiazole Amides as Viral Replication Inhibitors of Alphaviruses.4-取代-2-噻唑酰胺作为甲病毒的病毒复制抑制剂
J Med Chem. 2024 Dec 12;67(23):20858-20878. doi: 10.1021/acs.jmedchem.4c01073. Epub 2024 Dec 2.
10
Monoval-LdC: efficient prodrug of 2'-deoxy-beta-L-cytidine (L-dC), a potent and selective anti-HBV agent.单酯-LdC:2'-脱氧-β-L-胞苷(L-dC)的高效前药,一种强效且选择性的抗乙肝病毒药物。
Nucleosides Nucleotides Nucleic Acids. 2003 May-Aug;22(5-8):1003-6. doi: 10.1081/NCN-120022723.

引用本文的文献

1
Salicylamide derivatives as potent HBV inhibitors: insights into structure-activity relationships.水杨酰胺衍生物作为有效的乙肝病毒抑制剂:构效关系的见解
RSC Med Chem. 2025 May 8. doi: 10.1039/d5md00222b.
2
Convenient syntheses of 2-acylamino-4-halothiazoles and acylated derivatives using a versatile Boc-intermediate.使用通用的Boc中间体方便地合成2-酰氨基-4-卤代噻唑和酰化衍生物。
RSC Adv. 2024 Sep 2;14(38):27894-27903. doi: 10.1039/d4ra04959d. eCollection 2024 Aug 29.
3
Thiazolide Prodrug Esters and Derived Peptides: Synthesis and Activity.噻唑酯前药酯类及衍生肽:合成与活性
ACS Bio Med Chem Au. 2023 Apr 11;3(4):327-334. doi: 10.1021/acsbiomedchemau.2c00083. eCollection 2023 Aug 16.
4
Therapeutic potential of salicylamide derivatives for combating viral infections.水杨酰胺衍生物在抗病毒感染方面的治疗潜力。
Med Res Rev. 2023 Jul;43(4):897-931. doi: 10.1002/med.21940. Epub 2023 Mar 10.
5
Niclosamide as a Promising Therapeutic Player in Human Cancer and Other Diseases.尼氯硝唑——人类癌症及其他疾病治疗的新希望
Int J Mol Sci. 2022 Dec 17;23(24):16116. doi: 10.3390/ijms232416116.
6
Nitazoxanide induced myocardial injury in zebrafish embryos by activating oxidative stress response.硝唑尼特通过激活氧化应激反应诱导斑马鱼胚胎的心肌损伤。
J Cell Mol Med. 2021 Oct;25(20):9740-9752. doi: 10.1111/jcmm.16922. Epub 2021 Sep 17.
7
Safe-in-Man Broad Spectrum Antiviral Agents.安全人体广谱抗病毒药物。
Adv Exp Med Biol. 2021;1322:313-337. doi: 10.1007/978-981-16-0267-2_12.
8
Drug repurposing for the treatment of COVID-19: Pharmacological aspects and synthetic approaches.药物重用于 COVID-19 治疗:药理学方面和合成方法。
Bioorg Chem. 2021 Jan;106:104488. doi: 10.1016/j.bioorg.2020.104488. Epub 2020 Nov 19.
9
Therapeutic potential of Nitazoxanide against Newcastle disease virus: A possible modulation of host cytokines.硝唑尼特治疗新城疫病毒的潜力:对宿主细胞因子的可能调节。
Cytokine. 2020 Jul;131:155115. doi: 10.1016/j.cyto.2020.155115. Epub 2020 May 3.
10
Inhibitory Effects of Antiviral Drug Candidates on Canine Parvovirus in F81 cells.抗病毒候选药物对 F81 细胞中犬细小病毒的抑制作用。
Viruses. 2019 Aug 13;11(8):742. doi: 10.3390/v11080742.

本文引用的文献

1
Biological activity of modified and exchanged 2-amino-5-nitrothiazole amide analogues of nitazoxanide.硝唑尼特的 2-氨基-5-硝基噻唑酰胺类似物的修饰和交换的生物活性。
Bioorg Med Chem Lett. 2010 Jun 15;20(12):3537-9. doi: 10.1016/j.bmcl.2010.04.126. Epub 2010 May 18.
2
Treatment of chronic hepatitis C using a 4-week lead-in with nitazoxanide before peginterferon plus nitazoxanide.用硝唑尼特进行 4 周导入治疗,然后再用聚乙二醇干扰素加硝唑尼特治疗慢性丙型肝炎。
J Clin Gastroenterol. 2010 Aug;44(7):504-9. doi: 10.1097/MCG.0b013e3181bf9b15.
3
Evaluation of new thiazolide/thiadiazolide derivatives reveals nitro group-independent efficacy against in vitro development of Cryptosporidium parvum.评价新型噻唑烷/噻二唑烷衍生物对隐孢子虫体外发育的疗效,发现与硝基基团无关。
Antimicrob Agents Chemother. 2010 Mar;54(3):1315-8. doi: 10.1128/AAC.00614-09. Epub 2010 Jan 4.
4
The anti-hepatitis C agent nitazoxanide induces phosphorylation of eukaryotic initiation factor 2alpha via protein kinase activated by double-stranded RNA activation.抗丙型肝炎药物硝唑尼特通过双链RNA激活所激活的蛋白激酶诱导真核起始因子2α磷酸化。
Gastroenterology. 2009 Nov;137(5):1827-35. doi: 10.1053/j.gastro.2009.07.056. Epub 2009 Aug 4.
5
Thiazolides, a new class of anti-influenza molecules targeting viral hemagglutinin at the post-translational level.噻唑类化合物,一类新型的抗流感分子,在翻译后水平靶向病毒血凝素。
J Biol Chem. 2009 Oct 23;284(43):29798-808. doi: 10.1074/jbc.M109.029470. Epub 2009 Jul 28.
6
Thiazolides: a new class of antiviral drugs.噻唑酰胺类:一类新型抗病毒药物。
Expert Opin Drug Metab Toxicol. 2009 Jun;5(6):667-74. doi: 10.1517/17425250902988487.
7
In vitro efficacy of nitro- and halogeno-thiazolide/thiadiazolide derivatives against Sarcocystis neurona.硝基和卤代噻唑酯/噻二唑酯衍生物对犬新孢子虫的体外药效
Vet Parasitol. 2009 Jun 10;162(3-4):230-5. doi: 10.1016/j.vetpar.2009.03.022. Epub 2009 Mar 25.
8
Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B.乙肝疫苗接种:实现消除和根除乙肝的关键。
J Hepatol. 2009 Apr;50(4):805-16. doi: 10.1016/j.jhep.2009.01.002. Epub 2009 Feb 3.
9
Improved virologic response in chronic hepatitis C genotype 4 treated with nitazoxanide, peginterferon, and ribavirin.硝唑尼特、聚乙二醇干扰素和利巴韦林治疗慢性丙型肝炎基因4型的病毒学应答改善。
Gastroenterology. 2009 Mar;136(3):856-62. doi: 10.1053/j.gastro.2008.11.037. Epub 2008 Nov 19.
10
Potential for hepatitis C virus resistance to nitazoxanide or tizoxanide.丙型肝炎病毒对硝唑尼特或替唑尼特产生耐药性的可能性。
Antimicrob Agents Chemother. 2008 Nov;52(11):4069-71. doi: 10.1128/AAC.00078-08. Epub 2008 Aug 18.

噻唑烷类化合物作为新型抗病毒药物。1. 抑制乙型肝炎病毒复制。

Thiazolides as novel antiviral agents. 1. Inhibition of hepatitis B virus replication.

机构信息

Robert Robinson Laboratories, Department of Chemistry, University of Liverpool, Liverpool L69 7ZD, UK.

出版信息

J Med Chem. 2011 Jun 23;54(12):4119-32. doi: 10.1021/jm200153p. Epub 2011 May 23.

DOI:10.1021/jm200153p
PMID:21553812
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3124649/
Abstract

We report the syntheses and activities of a wide range of thiazolides [viz., 2-hydroxyaroyl-N-(thiazol-2-yl)amides] against hepatitis B virus replication, with QSAR analysis of our results. The prototypical thiazolide, nitazoxanide [2-hydroxybenzoyl-N-(5-nitrothiazol-2-yl)amide, NTZ] 1 is a broad spectrum antiinfective agent effective against anaerobic bacteria, viruses, and parasites. By contrast, 2-hydroxybenzoyl-N-(5-chlorothiazol-2-yl)amide 3 is a novel, potent, and selective inhibitor of hepatitis B replication (EC(50) = 0.33 μm) but is inactive against anaerobes. Several 4'- and 5'-substituted thiazolides show good activity against HBV; by contrast, some related salicyloylanilides show a narrower spectrum of activity. The ADME properties of 3 are similar to 1; viz., the O-acetate is an effective prodrug, and the O-aryl glucuronide is a major metabolite. The QSAR study shows a good correlation of observed EC(90) for intracellular virions with thiazolide structural parameters. Finally we discuss the mechanism of action of thiazolides in relation to the present results.

摘要

我们报告了一系列噻唑烷[即 2-羟基芳酰基-N-(噻唑-2-基)酰胺]的合成和抗乙型肝炎病毒复制活性,并对我们的结果进行了定量构效关系分析。典型的噻唑烷,硝唑尼特[2-羟基苯甲酰基-N-(5-硝基噻唑-2-基)酰胺,NTZ]1 是一种广谱抗感染药物,对厌氧菌、病毒和寄生虫均有效。相比之下,2-羟基苯甲酰基-N-(5-氯噻唑-2-基)酰胺 3 是一种新型、有效且选择性的乙型肝炎病毒复制抑制剂(EC(50)=0.33μm),但对厌氧菌无活性。一些 4'-和 5'-取代的噻唑烷对 HBV 具有良好的活性;相比之下,一些相关的水杨酰苯胺则显示出较窄的活性谱。3 的 ADME 性质与 1 相似;即,O-乙酸酯是一种有效的前药,O-芳基葡萄糖醛酸酯是主要代谢物。QSAR 研究表明,观察到的细胞内病毒的 EC(90)与噻唑烷结构参数之间存在良好的相关性。最后,我们讨论了噻唑烷的作用机制与目前结果的关系。